ESR1 and breast cancer: The three GQDs identified in the screening, GQD (1:3), o-GQD, and m-GQD, significantly reduced the viability of MCF-7 breast cancer cells, with o-GQD inducing the most significant reduction in the viability of ER+ breast cancer cells (28.36% at 72 h post-treatment) (Figure 1).